Senior, continuous teams
The Swiss profile describes project teams led by professionals with 15–30 years of experience, with emphasis on continuity throughout the study.

HIPPOCRATES RESEARCH / HR SWISS
A specialised CRO approach for innovative biotech and medtech sponsors, building on the experience and complementary capabilities of the Hippocrates Group.
Explore hr swiss ↓HIPPOCRATES RESEARCH SWISS
Hippocrates Research Swiss builds on the Hippocrates Group’s three decades of experience, combining a lean organisation with senior research expertise. Its approach is designed for biotech and medtech sponsors seeking direct involvement and continuity across clinical development.
The Swiss offering covers Phase I first-in-human and first-in-class programmes through Phase III. It combines a pan-European perspective with a particular focus on Switzerland and Italy, alongside scientific and regulatory support.
The Swiss profile describes project teams led by professionals with 15–30 years of experience, with emphasis on continuity throughout the study.
Engagement can include integrated regulatory consulting or Functional Service Provider arrangements, scaling to the sponsor’s requirements.
Study data and performance indicators support direct visibility into project progress and sponsor oversight.
CONNECTED DEVELOPMENT
Capabilities span rare diseases, oncology and high-technology medical devices, with multidisciplinary input for demanding protocols.
The Swiss profile describes support for accelerated pathways, including PRIME, orphan drug and breakthrough therapy routes, together with EMA, FDA and local regulatory expertise.
HR Swiss presents HomeTrial 360® for decentralized research and predictive analytics supporting recruitment and identification of investigative sites.
A lean organisational structure is intended to direct resources toward clinical work while maintaining close communication with sponsors.